EUCREAS

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug EUCREAS contains a combination of these active pharmaceutical ingredients (APIs):

1	Vildagliptin UNII I6B4B2U96P - VILDAGLIPTIN
	Vildagliptin enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion by increasing the endogenous levels of these incretin hormones. The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).
	Read more about Vildagliptin
2	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EUCREAS Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BD08	Metformin and vildagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1349322, 1349333, 1349344, 1349355, 1349366, 1349377, 1349388, 1349399, 1349401, 1349412, 1349423, 1349434
ES	Centro de información online de medicamentos de la AEMPS	07425003, 07425003IP, 07425003IP1, 07425003IP2, 07425009, 07425009IP, 07425009IP1, 07425009IP2, 07425021IP, 07425021IP1, 07425027IP, 07425027IP1
FI	Lääkealan turvallisuus- ja kehittämiskeskus	079885, 182805
FR	Base de données publique des médicaments	60892792
GB	Medicines & Healthcare Products Regulatory Agency	134124, 134127, 198740, 374363, 376366, 379891
IE	Health Products Regulatory Authority	24314, 24352, 24353
IL	מִשְׂרַד הַבְּרִיאוּת	6290, 7015, 7199
LT	Valstybinė vaistų kontrolės tarnyba	1028176, 1028177, 1028178, 1028179, 1028180, 1028181, 1028182, 1028183, 1028184, 1028185, 1028186, 1028187, 1028188, 1028189, 1028190, 1028191, 1028192, 1028193, 1077885, 1077886, 1077887, 1077888, 1077889, 1077890, 1077891, 1077892, 1077893, 1077894, 1077895, 1077896, 1077897, 1077898, 1077899, 1077900, 1077901, 1077902, 1091014, 1091015, 1091016, 1091017, 1091018, 1091019, 1091020, 1091021, 1091022, 1091023, 1091024, 1091025, 1091026, 1091027, 1091028, 1091029, 1091030, 1091031
NL	Z-Index G-Standaard, PRK	85952, 85960
PL	Rejestru Produktów Leczniczych	100182274, 100182280
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64469001, W64469002, W64469003, W64469004, W64469005, W64469006, W64469007, W64469008, W64469009, W64470001, W64470002, W64470003, W64470004, W64470005, W64470006, W64470007, W64470008, W64470009